Scholarlink

<p>Cholangiocarcinoma (CC) is an aggressive cancer with limited prognostic biomarkers. Aquaporin 1 (AQP1), a water channel protein, is implicated in cancer progression. Moreover, DNA methylation plays a key role in epigenetic gene regulation. Therefore, the present study aimed to investigate the prognostic significance of <i>AQP1</i> promoter methylation haplotypes in CC using high-resolution bisulfite amplicon sequencing. <i>AQP1</i> mRNA expression in 102 patients was evaluated first to examine its prognostic impact. Subsequently, methylation haplotypes in non-neoplastic and neoplastic tissues from 96 patients were analyzed. Methylation heterogeneity was assessed using t-distributed stochastic neighbor embedding (t-SNE) and k-means clustering. Although AQP1 mRNA expression alone was not a robust independent prognostic factor, a t-SNE-based classification of the methylation signature identified two subgroups with distinct overall survival in both non-neoplastic and neoplastic tissues. Multivariate analysis using Firth’s penalized Cox regression indicated that this methylation signature was independently associated with prognosis (hazard ratio 0.322, <i>p</i> = 0.001). Similar haplotype alterations were observed in non-neoplastic and neoplastic tissues, consistent with the possibility of an epigenetic field effect. These findings suggest that evaluating the methylation signature of the <i>AQP1</i> promoter may support future less-invasive prognostic assessment and risk stratification, suggesting its potential utility as a candidate biomarker in CC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Methylation heterogeneity of the AQP1 promoter as a candidate prognostic biomarker in cholangiocarcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月25日

查看全文
  • Seiya Yokoyama,
  • Hirotsugu Noguchi,
  • Taiji Hamada,
  • Kei Matsuo,
  • Toshiaki Akahane,
  • Ikumi Kitazono,
  • Takashi Tasaki,
  • Miki Murakami,
  • Takao Ohtsuka,
  • Michiyo Higashi,
  • Tatsuhiko Furukawa,
  • Akihide Tanimoto

摘要

Cholangiocarcinoma (CC) is an aggressive cancer with limited prognostic biomarkers. Aquaporin 1 (AQP1), a water channel protein, is implicated in cancer progression. Moreover, DNA methylation plays a key role in epigenetic gene regulation. Therefore, the present study aimed to investigate the prognostic significance of AQP1 promoter methylation haplotypes in CC using high-resolution bisulfite amplicon sequencing. AQP1 mRNA expression in 102 patients was evaluated first to examine its prognostic impact. Subsequently, methylation haplotypes in non-neoplastic and neoplastic tissues from 96 patients were analyzed. Methylation heterogeneity was assessed using t-distributed stochastic neighbor embedding (t-SNE) and k-means clustering. Although AQP1 mRNA expression alone was not a robust independent prognostic factor, a t-SNE-based classification of the methylation signature identified two subgroups with distinct overall survival in both non-neoplastic and neoplastic tissues. Multivariate analysis using Firth’s penalized Cox regression indicated that this methylation signature was independently associated with prognosis (hazard ratio 0.322, p = 0.001). Similar haplotype alterations were observed in non-neoplastic and neoplastic tissues, consistent with the possibility of an epigenetic field effect. These findings suggest that evaluating the methylation signature of the AQP1 promoter may support future less-invasive prognostic assessment and risk stratification, suggesting its potential utility as a candidate biomarker in CC.